S&P 500   4,552.57 (-0.32%)
DOW   34,273.02 (-0.61%)
QQQ   389.87 (-1.00%)
AAPL   165.54 (+0.15%)
MSFT   332.89 (+0.70%)
FB   312.66 (-3.64%)
GOOGL   2,845.52 (+0.27%)
AMZN   3,458.79 (-1.38%)
TSLA   1,107.39 (-3.26%)
NVDA   316.54 (-3.13%)
BABA   122.75 (-3.75%)
NIO   38.47 (-1.69%)
CGC   10.01 (-6.54%)
AMD   149.95 (-5.32%)
GE   94.01 (-1.03%)
MU   85.83 (+2.18%)
T   22.34 (-2.15%)
F   19.78 (+3.07%)
DIS   142.88 (-1.39%)
AMC   28.22 (-16.85%)
PFE   54.79 (+1.97%)
ACB   6.04 (-5.92%)
BA   190.30 (-3.82%)
S&P 500   4,552.57 (-0.32%)
DOW   34,273.02 (-0.61%)
QQQ   389.87 (-1.00%)
AAPL   165.54 (+0.15%)
MSFT   332.89 (+0.70%)
FB   312.66 (-3.64%)
GOOGL   2,845.52 (+0.27%)
AMZN   3,458.79 (-1.38%)
TSLA   1,107.39 (-3.26%)
NVDA   316.54 (-3.13%)
BABA   122.75 (-3.75%)
NIO   38.47 (-1.69%)
CGC   10.01 (-6.54%)
AMD   149.95 (-5.32%)
GE   94.01 (-1.03%)
MU   85.83 (+2.18%)
T   22.34 (-2.15%)
F   19.78 (+3.07%)
DIS   142.88 (-1.39%)
AMC   28.22 (-16.85%)
PFE   54.79 (+1.97%)
ACB   6.04 (-5.92%)
BA   190.30 (-3.82%)
S&P 500   4,552.57 (-0.32%)
DOW   34,273.02 (-0.61%)
QQQ   389.87 (-1.00%)
AAPL   165.54 (+0.15%)
MSFT   332.89 (+0.70%)
FB   312.66 (-3.64%)
GOOGL   2,845.52 (+0.27%)
AMZN   3,458.79 (-1.38%)
TSLA   1,107.39 (-3.26%)
NVDA   316.54 (-3.13%)
BABA   122.75 (-3.75%)
NIO   38.47 (-1.69%)
CGC   10.01 (-6.54%)
AMD   149.95 (-5.32%)
GE   94.01 (-1.03%)
MU   85.83 (+2.18%)
T   22.34 (-2.15%)
F   19.78 (+3.07%)
DIS   142.88 (-1.39%)
AMC   28.22 (-16.85%)
PFE   54.79 (+1.97%)
ACB   6.04 (-5.92%)
BA   190.30 (-3.82%)
S&P 500   4,552.57 (-0.32%)
DOW   34,273.02 (-0.61%)
QQQ   389.87 (-1.00%)
AAPL   165.54 (+0.15%)
MSFT   332.89 (+0.70%)
FB   312.66 (-3.64%)
GOOGL   2,845.52 (+0.27%)
AMZN   3,458.79 (-1.38%)
TSLA   1,107.39 (-3.26%)
NVDA   316.54 (-3.13%)
BABA   122.75 (-3.75%)
NIO   38.47 (-1.69%)
CGC   10.01 (-6.54%)
AMD   149.95 (-5.32%)
GE   94.01 (-1.03%)
MU   85.83 (+2.18%)
T   22.34 (-2.15%)
F   19.78 (+3.07%)
DIS   142.88 (-1.39%)
AMC   28.22 (-16.85%)
PFE   54.79 (+1.97%)
ACB   6.04 (-5.92%)
BA   190.30 (-3.82%)
NASDAQ:APDN

Applied DNA Sciences Stock Forecast, Price & News

$5.26
-0.52 (-9.00%)
(As of 12/1/2021 03:29 PM ET)
Add
Compare
Today's Range
$5.00
$5.62
50-Day Range
$4.68
$6.06
52-Week Range
$4.65
$13.64
Volume
12,921 shs
Average Volume
939,514 shs
Market Capitalization
$39.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.98
30 days | 90 days | 365 days | Advanced Chart
Receive APDN News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter.


Applied DNA Sciences logo

About Applied DNA Sciences

Applied DNA Sciences, Inc. engages in the provision of security solutions. The firm offers molecular-based technology solutions and services that can help protect products, brands, supply chains, and intellectual property of companies, governments, and consumers from theft, counterfeiting, fraud, and diversion. Its products include the following brands: Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, DNAnet, LinearDNA, SigNify, Linea, Beacon, and CertainT. The company was founded in 1983 and is headquartered in Stony Brook, NY.

Headlines

Synthetic DNA startup Catalog raises $35M to speed up computation
October 10, 2021 |  markets.businessinsider.com
See More Headlines

Industry, Sector and Symbol

Industry
Miscellaneous business services
Sub-Industry
N/A
Current Symbol
NASDAQ:APDN
Employees
60
Year Founded
N/A

Sales & Book Value

Annual Sales
$1.93 million
Book Value
$1.11 per share

Profitability

Net Income
$-13.03 million
Net Margins
-220.18%
Pretax Margin
-220.50%

Debt

Price-To-Earnings

Miscellaneous

Free Float
6,957,000
Market Cap
$39.38 million
Optionable
Optionable

Company Calendar

Last Earnings
8/11/2021
Today
12/01/2021
Next Earnings (Estimated)
12/16/2021
Fiscal Year End
9/30/2022

MarketRank

Overall MarketRank

1.76 out of 5 stars

Industrial Products Sector

172nd out of 246 stocks

Miscellaneous Business Services Industry

7th out of 7 stocks

Analyst Opinion: 3.5Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -












Applied DNA Sciences (NASDAQ:APDN) Frequently Asked Questions

Is Applied DNA Sciences a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Applied DNA Sciences in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Applied DNA Sciences stock.
View analyst ratings for Applied DNA Sciences
or view top-rated stocks.

How has Applied DNA Sciences' stock price been impacted by Coronavirus (COVID-19)?

Applied DNA Sciences' stock was trading at $4.10 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, APDN stock has increased by 28.3% and is now trading at $5.26.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Applied DNA Sciences?

Applied DNA Sciences saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 592,500 shares, an increase of 78.5% from the October 31st total of 332,000 shares. Based on an average trading volume of 442,600 shares, the short-interest ratio is currently 1.3 days. Approximately 8.7% of the company's stock are short sold.
View Applied DNA Sciences' Short Interest
.

When is Applied DNA Sciences' next earnings date?

Applied DNA Sciences is scheduled to release its next quarterly earnings announcement on Thursday, December 16th 2021.
View our earnings forecast for Applied DNA Sciences
.

How were Applied DNA Sciences' earnings last quarter?

Applied DNA Sciences, Inc. (NASDAQ:APDN) announced its quarterly earnings data on Wednesday, August, 11th. The technology company reported ($0.46) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.26) by $0.20. The technology company earned $1.70 million during the quarter, compared to analysts' expectations of $3.44 million. Applied DNA Sciences had a negative trailing twelve-month return on equity of 116.69% and a negative net margin of 220.18%.
View Applied DNA Sciences' earnings history
.

What price target have analysts set for APDN?

3 equities research analysts have issued 1 year target prices for Applied DNA Sciences' stock. Their forecasts range from $11.00 to $24.00. On average, they anticipate Applied DNA Sciences' stock price to reach $17.67 in the next year. This suggests a possible upside of 235.9% from the stock's current price.
View analysts' price targets for Applied DNA Sciences
or view top-rated stocks among Wall Street analysts.

Who are Applied DNA Sciences' key executives?

Applied DNA Sciences' management team includes the following people:
  • James A. Hayward, Chairman, President & Chief Executive Officer
  • Judy Murrah, Chief Operating Officer
  • Beth M. Jantzen, Chief Financial Officer & Controller
  • Barbara Brockway, Director-Personal Care
  • Wayne Buchen, Vice President-Strategic Sales

What is James A. Hayward's approval rating as Applied DNA Sciences' CEO?

2 employees have rated Applied DNA Sciences CEO James A. Hayward on Glassdoor.com. James A. Hayward has an approval rating of 100% among Applied DNA Sciences' employees. This puts James A. Hayward in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Applied DNA Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Applied DNA Sciences investors own include Inovio Pharmaceuticals (INO), Advanced Micro Devices (AMD), Ekso Bionics (EKSO), Micron Technology (MU), Arbutus Biopharma (ABUS), VBI Vaccines (VBIV), Gilead Sciences (GILD), Vaxart (VXRT), Sorrento Therapeutics (SRNE) and Intel (INTC).

What is Applied DNA Sciences' stock symbol?

Applied DNA Sciences trades on the NASDAQ under the ticker symbol "APDN."

Who are Applied DNA Sciences' major shareholders?

Applied DNA Sciences' stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (1.03%), Geode Capital Management LLC (0.71%), Dimensional Fund Advisors LP (0.26%), Delta Investment Management LLC (0.20%), Citadel Advisors LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%).
View institutional ownership trends for Applied DNA Sciences
.

Which major investors are buying Applied DNA Sciences stock?

APDN stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Geode Capital Management LLC, Citadel Advisors LLC, Delta Investment Management LLC, and Dimensional Fund Advisors LP.
View insider buying and selling activity for Applied DNA Sciences
or or view top insider-buying stocks.

How do I buy shares of Applied DNA Sciences?

Shares of APDN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Applied DNA Sciences' stock price today?

One share of APDN stock can currently be purchased for approximately $5.26.

How much money does Applied DNA Sciences make?

Applied DNA Sciences has a market capitalization of $39.38 million and generates $1.93 million in revenue each year. The technology company earns $-13.03 million in net income (profit) each year or ($2.37) on an earnings per share basis.

How many employees does Applied DNA Sciences have?

Applied DNA Sciences employs 60 workers across the globe.

What is Applied DNA Sciences' official website?

The official website for Applied DNA Sciences is www.adnas.com.

Where are Applied DNA Sciences' headquarters?

Applied DNA Sciences is headquartered at 50 HEALTH SCIENCES DRIVE, STONY BROOK NY, 11790.

How can I contact Applied DNA Sciences?

Applied DNA Sciences' mailing address is 50 HEALTH SCIENCES DRIVE, STONY BROOK NY, 11790. The technology company can be reached via phone at (631) 240-8800, via email at [email protected], or via fax at 631-240-8900.


This page was last updated on 12/1/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.